SARALYN GOFF: Open Payments
NPI 1134802523 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 19 payments from 9 companies in 2025. Trend: 2023 $60 · 2024 $528 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| PFIZER INC. | 3 | $46 |
| Amgen Inc. | 2 | $29 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LifeVest, JARDIANCE, CAMZYOS, REPATHA, VYNDAQEL, FUROSCIX, ELIQUIS, Attruby.
Industry payments across GA — which companies pay providers there.
